top of page

Technical Article

ICH Q9(R1) Quality Risk Management: Principles, Tools & Applications​

​

​

Seetharam Kandarpa

SEETHARAM (RAM) KANDARPA
MS Data Science, ASQConnEx Expert, ASQ CMQ/OE, ASQ CQA, ASQ CQE, ASQ CMDA, ASQ CSQP, ASQ CSQE, ASQ CPGP,
ASQ CSSGB, RAC Drugs, RAC Devices, PMP, LSSBB

Founder and Director

​

Shaarkview Consultancy

1.0  Introduction​

ICH Q9

​

 

ICH Q9(R1) Quality Risk Management (QRM) provides a systematic, science-based approach for identifying, assessing, controlling, communicating, and reviewing risks to pharmaceutical product quality throughout the product lifecycle. This guide explains the key principles of ICH Q9(R1), important QRM tools such as FMEA, FTA, HACCP and HAZOP, risk-based decision-making, and practical applications across pharmaceutical development, manufacturing, quality systems, and regulatory operations.

 

In today’s highly regulated pharmaceutical and biotech sectors, the ICH Q9 guideline on Quality Risk Management (QRM) remains a foundational element in safeguarding product quality and ensuring patient safety. Developed by the International Council for Harmonisation (ICH), Q9 introduces a structured approach to identifying, evaluating, and mitigating risks across the product lifecycle.

 

The purpose of ICH Q9 (R1- 2023 revision) [1] is to offer a systematic approach to quality risk management that leads to better, more informed, and timely decisions. It specifically provides guidance on the principles and some of the tools of quality risk management that can enable more effective and consistent risk-based decisions, both by regulators and industry, regarding the quality of drug substances and drug (medicinal) products across the product lifecycle. 

 

These aspects include development, manufacturing, distribution, and the inspection and submission/review processes throughout the lifecycle of drug substances, drug (medicinal) products, biological and biotechnological products (including the use of raw materials, solvents, excipients, packaging and labeling materials in drug (medicinal) products, biological and biotechnological products).

​​​

2.0  Principles of Quality Risk Management 

ICH Q9 QRM Flow

​​

Two primary principles of quality risk management are:

 

  • The evaluation of the risk to quality should be based on scientific knowledge and ultimately link to the protection of the patient. (Note: Risk to quality includes situations where product availability may be impacted, leading to potential patient harm.)

  • The level of effort, formality and documentation of the quality risk management process should be commensurate with the level of risk.

​​​

3.0  What Changed in ICH Q9(R1)?

​​​​

  • Better clarity on subjectivity in risk assessments, including factors that influence risk perception.

  • Enhanced guidance on risk-based decision-making and communication.

  • Improved understanding of hazard identification and risk acceptance criteria.

  • Acknowledgment of digital transformation in QRM processes.

​​​

ICH Q9
image.png

4.0  Key Challenges of Industry

​​​​

  • Aligning QRM approaches across global operations.

  • Training gaps and inconsistent application of risk tools.

  • Difficulty in balancing risk mitigation with operational agility.

  • Cultural resistance to transparent risk-based decision-making.

​​​

5.0  Current Trends in Quality Risk Management

​​​​

  • Increased integration of digital tools, AI/ML models, and data analytics into risk identification and control.

  • Cross-functional QRM teams incorporating regulatory, digital, and process experts.

  • Emphasis on real-time risk monitoring in continuous and adaptive manufacturing environments.​​​

6.0  Regulatory Inspection Trends

​​​​

  • Increased scrutiny on risk documentation and traceability.

  • Regulators expect evidence of QRM in deviation investigations and change management.

  • Emphasis on lifecycle application of QRM, especially during technology transfer and scale-up.

  • Inspectors are evaluating if QRM is used proactively rather than reactively.

7.0  Quality Risk Management Methods and Tools (Covered in Annex I)

​​​​

  • Basic risk management facilitation methods (flowcharts, check sheets, etc.)

  • Failure mode effects analysis (FMEA)

  • Failure mode, effects and criticality analysis (FMECA)

  • Fault tree analysis (FTA)

  • Hazard analysis and critical control points (HACCP)

  • Hazard operability analysis (HAZOP)

  • Preliminary hazard analysis (PHA)

  • Risk ranking and filtering

  • Supporting statistical tools

8.0  Potential Applications for Quality Risk Management (Covered in Annex II)

​​​​

  • Integrated quality management

  • Regulatory operations inspection and assessment activities

  • Development

  • Facilities, equipment and utilities

  • Materials management

  • Production

  • Laboratory control and stability studies

  • Packaging and labelling

  • Supply chain control

9.0  Key Things To Remember

​​​​

  • ICH Q9 is not a means to justify pre-determined outcomes/decisions.

  • It is not a means to justify poor practices, poor product quality or ineffective processes.

  • QRM should not be used in a manner where decisions are made that justify a practice that would otherwise, in accordance with regulations and/or guidance, be deemed unacceptable.”

  • Drive the integration of QRM within existing quality system elements and activities.

  • Promote a culture of risk-awareness.

  • ICH Q9 is not intended to be a stand-alone guideline used in isolation- many other ICH quality guidelines refer to risk, QRM and risk-based approaches.

10.0  Conclusion

​​

ICH Q9 encourages science-based, systematic risk evaluation to drive quality, compliance, and patient safety. With the 2025 revision (Q9 R1), the framework is more aligned with modern technologies and decision-making expectations. For companies, mastering QRM is not just about meeting regulatory requirements—it’s a competitive advantage.

​​​

11.0  References

​​​

​​​

bottom of page